Literature DB >> 11520718

The kinetics of allergen-induced eotaxin level in nasal lavage fluid: its key role in eosinophil recruitment in nasal mucosa.

N Terada1, N Hamano, W J Kim, K Hirai, T Nakajima, H Yamada, H Kawasaki, T Yamashita, H Kishi, T Nomura, T Numata, O Yoshie, A Konno.   

Abstract

Eotaxin (CCL11) is a potent eosinophil chemoattractant belonging to the C-C chemokine. To evaluate the role of eotaxin in eosinophilic inflammation in nasal mucosa, we investigated the levels of eosinophil chemoattractants in nasal lavage fluids obtained after antigen challenge, compared with eosinophil counts and eosinophil protein X (EPX) levels. In subjects with allergic rhinitis, allergen challenge led to parallel increases in eosinophil counts, levels of EPX, and eotaxin concentrations in nasal lavage fluid. The levels of eotaxin in lavage samples showed strong correlation with lavage levels of eosinophil counts and EPX. Normal subjects had few, if any, eosinophils and EPX as well as the measured parameters in their nasal lavage fluids before and after antigen challenge. In our experiments of eosinophil endothelial transmigration (TEM) assay using the nasal microvascular endothelial cells, eotaxin showed the most potent effect among various eosinophil chemoattractants. In addition, treatment of eosinophils with anti-CCR-3 mAb significantly blocked eosinophil TEM induced by homogenate of nasal mucosa. These results indicate that eotaxin has an important role in eosinophil-dependent inflammation in nasal mucosa and suggest that blocking eotaxin or CCR-3 might be useful for new therapeutic tools of allergic rhinitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11520718     DOI: 10.1164/ajrccm.164.4.2009046

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  8 in total

Review 1.  Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies.

Authors:  Manuel A R Ferreira
Journal:  Mediators Inflamm       Date:  2003-10       Impact factor: 4.711

Review 2.  Cytokine profiles in allergic rhinitis.

Authors:  Guy Scadding
Journal:  Curr Allergy Asthma Rep       Date:  2014-05       Impact factor: 4.806

3.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

4.  Effects of a dual CCR3 and H1-antagonist on symptoms and eosinophilic inflammation in allergic rhinitis.

Authors:  Lennart Greiff; Cecilia Ahlström-Emanuelsson; Ash Bahl; Thomas Bengtsson; Kerstin Dahlström; Jonas Erjefält; Henrik Widegren; Morgan Andersson
Journal:  Respir Res       Date:  2010-02-09

5.  Differential serum levels of eosinophilic eotaxins in primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis.

Authors:  Abdolamir Landi; Tobias J Weismuller; Tim O Lankisch; Deanna M Santer; D Lorne J Tyrrell; Michael P Manns; Michael Houghton
Journal:  J Interferon Cytokine Res       Date:  2013-10-29       Impact factor: 2.607

6.  Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge.

Authors:  G W Scadding; A O Eifan; M Lao-Araya; M Penagos; S Y Poon; E Steveling; R Yan; A Switzer; D Phippard; A Togias; M H Shamji; S R Durham
Journal:  Allergy       Date:  2015-04-06       Impact factor: 13.146

7.  Reproducibility of nasal allergen challenge responses in adults with allergic rhinitis.

Authors:  Charles T Pantin; Thomas Southworth; Kristiane Wetzel; Dave Singh
Journal:  Clin Pharmacol       Date:  2019-05-13

8.  Effect of cigarette smoke on counts of immunoreactive cells to eotaxin-1 and eosinophils on the nasal mucosa in young patients with perennial allergic rhinitis.

Authors:  Bertha Beatriz Montaño-Velázquez; Eulalia Beatriz Flores-Rojas; Francisco Javier García-Vázquez; Silvio Jurado-Hernandez; Marco Antonio Venancio Hernández; Angélica Kathya Alanis Flores; Kathrine Jáuregui-Renaud
Journal:  Braz J Otorhinolaryngol       Date:  2016-05-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.